data have indicated pure curcumin inhibited cancer cell proliferat

Conditional cytotoxic methods present no cytotoxic enzymes into the prodrugs are converted by the glioma which upon prodrug administration into harmful toxins effective at eradicating tumors. Anti angiogenic paradigms are Cilengitide created to prevent the vascularization of tumors that will be necessary for metastasis and growth. Immune stimulatory methods seek to use the patients own immune system to target and destroy cancers, this approach essentially also could include induction of immunological memory to protect against infection recurrence. Specific toxin methods utilize receptors specifically overexpressed on glioma cells to target the contaminants directly into cancer cells, specifically destroying these cells. Furthermore, as therapeutic target tumor suppressor and oncogenes are targets for gene therapy and utilize the genetic abnormalities of the tumor. Substantial development characterizing potential solutions preclinically has happened in most five target regions and will be defined in subsequent sections. Plastid In targeting brain tumors with conditionally cytotoxic therapies the target would be to obtain very specific destruction of cancer cells without toxicity on track tissues or induction of systemic immune response against balanced tissuesorgans. Conditionally cytotoxic gene-therapy gives an enzyme into tumor cells which can be non cytotoxic until the administration of likewise, non cytotoxic prodrug. Upon prodrug administration, the healing enzyme converts the non cytotoxic prodrug into toxic metabolite able to cause cell death. Preliminary investigations sought to exploit prodrug activation utilizing PF-543 endogenous enzymes expressed at higher levels in tumor cells, however, scientific program was limited since these enzymes were expressed in normal cells and only small number of human malignancies had high enough levels of activating enzymes to generate effectiveness in cancer treatment. To overcome these problems, identification of non mammalian enzymeprodrug combinations was undertaken. Usage of infections to specially offer nutrients to tumors has produced promising leads to vitro and in vivo. For therapy to achieve success the molecule must certanly be expressed exclusively inside the tumor cells and its catalytic action be large enough for clinical benefit without toxicity on track tissues. Significant bystander effect is essential, since expression will not arise in all cancer tissues. Bystander effects arise when the cytotoxic metabolite is given to cells not originally transduced with all the molecule. This may occur via transport through gap junctions or by diffusion through the extracellular space. In addition to delivery of the enzyme, delivery of the prodrug have to be delayed sufficiently allowing expression of the enzyme in targeted tissue. large number of enzymeprodrug permutations have been found and characterized in brain tumor treatment. The most well-characterized conditionally cytotoxic combinations are herpes virus type 1 thymidine kinase ganciclovir and cytosine deaminase 5 fluorocytosine.